The stock of Proto Labs, Inc. (NYSE:PRLB) has been Initiated to Buy by Northcoast in its latest research note that was published on December 12. PRLB was given a price target of $145, with other Wall Street analysts also giving their reports regarding the stock. Berenberg, analysts launched coverage of PRLB stock with a Buy rating, according to their flash note to investors on November 14. Analysts at Dougherty & Company issued an upgrade fromSell to Neutral for the stock, in a research note that dated back to June 27.
Proto’s stock is covered by 6 analysts, with 3 of them rating the stock as Buy. It has been deemed to have strong buy by none of the analysts, 3 of them have rated it as a Hold while none of them rated it as sell. The situation was different a month ago when the stock was rated as a Buy by only 3 analysts. none of them rated it as strong buy with 3 of them recommended investors to Hold on to the stock. Meanwhile, none analyst(s) rated it as a sell. The above data shows that PRLB has an average analyst rating of 2.00.
Proto Labs, Inc., which has current market capitalization of above $3 Billion, published its last quarter earnings on June 30, 2019. The company was able to amass $115.93 million in revenue. This figure is $0.55 million more than what analysts had expected which was $116.49 million. During the first quarter of the year, Proto also recorded $0.71 earnings per share (EPS) which is $0.01 above the $0.7 estimated by Thomson Reuter’s analyst, leading to a surprise factor of 1.75%.
PRLB surged by $5.26 during the normal trading session on Tuesday and reaching a high of $99.38 during the day while it closed the day at $97.14. The Proto stock had a low trading volume of 0.13 million shares on that day, which is low compared to the average daily volume of 197.13M shares. PRLB has also lost 0.00% of its value over the past 7 days. However, the stock has declined by 8.43% in the 3 months of the year. Over the past six months meanwhile, it has lost 6.60% while it has lost 13.88% year-on date. Let us now take a look at the stock’s potential support and resistance levels. The publicly traded company was seen to have slipped by -18.91% from its 3 months high price. However, taking another look at PRLB will indicate that it is trading +3.63% away from its 90-day low. Looking at the bigger picture, the Proto Labs, Inc. stock has dropped by -41.69% from its 52-week high while it has surged by +3.63% from its 52-week low price.
On September 24, 2018 WAY JOHN, CFO sold 8000 shares of the company. The average price for that transaction was $159.1 per share, which meant that WAY JOHN earned $1272800 selling the stocks. The sale was made public, with the document of the transaction filed with the SEC. Another insider trading occurred, with Director, Goodman John B selling 1113 shares of this stock on September 14, 2018. The average selling price for the stock was $162.95 per share, with the sold stock accruing $181363.4. Following this transaction, the Director Goodman John B now holds 15489 shares of the company, which is worth around $1457825.
Proto has around 101 Billion cash on their books at the moment. This figure will have to be compared and looked into, with their current liabilities standing at $51 Billion. The Proto stock is bringing in revenue of over 12 months, which is roughly 116 Billion. Despite all that, Proto Labs, Inc. is seeing things progressing very much as their y-o-y quarterly revenue surged by 5.73%.
Looking at the stock’s Technical analysis information over the past 50 days shows that its Raw Stochastic average stood at 13.05%. This figure is worse than the company’s 20-day Raw Stochastic average which currently stands at 22.52%. Over the past 20 days, Proto’s Stochastic %K stood at 11.12% while its Stochastic %D was revealed to be 12.96%.